Navigation Links
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Date:6/30/2008

Company Announces Revised Operating Plan to Respond to NEBIDO Delay

LEXINGTON, Mass., June 30 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for NEBIDO(R) related to a New Drug Application (NDA) submitted to the FDA in August 2007. The letter, received on June 27, 2008, indicated that the application may be approved if the Company is able to adequately respond to certain clinical deficiencies related to the product. The letter generally confirmed the Company's previously-announced indications from the FDA based on telephone discussions.

The FDA has expressed a concern about a relatively small number of patients in European post-marketing use who have experienced respiratory symptoms immediately following the intramuscular injection of NEBIDO 1000 mg, 4 cc injection volume, (versus the 750 mg, 3 cc injection volume used in the United States). The Company believes and the FDA concurs that the reaction is likely the result of a small amount of the oily solution immediately entering the vascular system from the injection site, a known, rare complication of oil-based depot injections.

The phenomenon is characterized by short-term reactions involving an urge to cough, coughing episodes or a shortness of breath. In rare cases the reaction has been classified as serious or the patient experiences other symptoms such as dizziness, flushing or fainting. In the Company's U.S. clinical trials of NEBIDO 750 mg (3 cc injection volume), the proposed dose in the U.S., there was a single, mild, non-serious case of oil-based cough observed. In addition, the FDA believes that four cases in the European post-
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Indevus Announces Management Changes
2. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
3. 125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative
4. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
5. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
6. Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
7. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
8. Indevus Announces Allergan as New Partner for SANCTURA Brand
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Alfacell Receives NASDAQ Non-Compliance Notification
11. Albany College of Pharmacy Researcher Receives $368,445 Grant from the National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02316662/Global-Chelating-Agents-Market-2014-2018.html About Chelating Agent ... can form covalent bonds with metal ions, thereby ... effect that some metal-ions have on chemical processes, ...
(Date:8/27/2014)... Mass. (PRWEB) August 27, 2014 “We ... top technology vendors,” said Ven Thangaraj, CEO of Radiant ... solutions that are taking the imaging corelab market to ... sponsors, corelabs and research organizations to efficiently and effectively ... prepare the data to be analyzed and read by ...
(Date:8/27/2014)... 27, 2014 Research and Markets ... for Pulp & Paper Industry Report 2014" report ... for Pulp & Paper Industry Report 2014 is a ... the global enzyme for pulp & paper industry. ... industry including definitions, classifications, applications and industry chain structure. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Riviera ... is announcing the creation of the Sancilio Scientific ... take the SCI’s philosophy of looking to nature ... and development actions are based on sound scientific ... Scientific Advisory Board provides a vehicle for SCI ...
Breaking Biology Technology:Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Global Enzyme for Pulp & Paper Industry Report 2014 2New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3
... Key words: adenoviral ... gene delivery, , ... cells can greatly aid secondary screening as well as lead and ... systems to express target genes of interest at detectable levels takes ...
... , ... transduction • EGFP • IN Cell Analyzer • gene delivery, ... Biological assays developed in cultured and primary cells can greatly ... their development presents several challenges. Establishing stable cell systems to express ...
... , ... IN Cell Analyzer, , ... of genotoxic compounds and analysis of micronuclei formation resulting from DNA ... important component of toxicology screening of new drug candidates. Manual scoring ...
Cached Biology Technology:Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 2Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 3Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 4Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 5Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 6Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 7Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 2Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 3Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 4Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 5Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 6Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 7Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 8Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 9Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system 10Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 2Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 3Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 4Analysis of in vitro micronucleus assays using the IN Cell Analyzer 3000 Micronuclei Formation Analysis Module 5
(Date:8/27/2014)... mastodons, short-faced bears, giant ground sloths, saber-toothed cats ... 13,000 years ago at the end of the Pleistocene ... been debated by scientists who, until recently, could only ... including UC Santa Barbara,s James Kennett, professor emeritus in ... collision with Earth played a major role in the ...
(Date:8/27/2014)... University researchers have identified a gene that could help ... a protein in the cell membrane of plants that ... water conservation machinery accordingly. , "It,s similar to ... biology at Duke. , The findings, which appear ... make it easier to feed the world,s growing population ...
(Date:8/27/2014)... skill is easier when it is related to ability ... might learn a new melody more easily than learning ... from the Center for the Neural Basis of Cognition ... Carnegie Mellon Universityhave discovered a fundamental constraint in the ... the cover story in the Aug. 28, 2014, issue ...
Breaking Biology News(10 mins):Nanodiamonds are forever 2Nanodiamonds are forever 3Water 'thermostat' could help engineer drought-resistant crops 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3
... dioxide injected deep underground to help fight climate change could ... up levels of contaminants in the water tenfold or more ... scientists. Based on a year-long analysis of core samples ... contamination is real, but there are ways to avoid or ...
... For Immediate Release Scientists from the Florida campus ... first time a novel mechanism that regulates circadian rhythm, ... physiological cycle. These new findings could provide a new ... sleep disturbances, but also for disorders that result from ...
... Researchers report that a drug commonly used to treat ... of the most common genetic disorder, polycystic kidney disease. ... affects one in 1,000 adults worldwide. Researchers ... University-Purdue University Indianapolis and colleagues from the Mayo Clinic ...
Cached Biology News:Leaking underground CO2 storage could contaminate drinking water 2Scripps Research scientists identify new mechanism regulating daily biological rhythms 2Scripps Research scientists identify new mechanism regulating daily biological rhythms 3Common diabetes drug may halt growth of cysts in polycystic kidney disease 2
Request Info...
Limit of detection: <5 pg/ml...
... custom siRNA service provides the premium quality ... research. Custom siRNAs can be readily ordered ... target sequence, or by providing the sense ... Ambion's Silencer Validated and Silencer Pre-designed siRNAs, ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Biology Products: